DBV Technologies SA - ADR (DBVT) Price & News - Google Finance (2024)

Dow Futures$38,807.00+0.26%+$101.00Dow Futures$38,807.000.26%
Nasdaq Futures$18,154.25+0.61%+$110.00Nasdaq Futures$18,154.250.61%
Gold$2,166.90+0.40%+$8.70Gold$2,166.900.40%
Crude Oil$78.75-0.48%-$0.38Crude Oil$78.750.48%

HomeDBVT • NASDAQ

DBV Technologies SA - ADR

$0.85

Pre-market:

$0.81

(4.93%)-0.042

Closed: Mar 7, 9:09:34 AM GMT-5 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Seres Therapeutics Inc

$1.01

MCRB0.00%

Denali Therapeutics Inc

$20.52

DNLI0.34%

Prelude Therapeutics Inc

$4.17

PRLD0.48%

Cidara Therapeutics Inc

$0.70

CDTX0.086%

Bicycle Therapeutics PLC

$24.64

BCYC0.081%

ROIV

$11.57

ROIV0.00%

Immunovant Inc

$33.06

IMVT0.00%

Veru Inc

$0.64

VERU0.00%

Citius Pharmaceuticals Inc

$0.72

CTXR0.00%

Ideaya Biosciences Inc

$46.36

IDYA0.00%

Financials

Income Statement

Revenue

Net income

(USD)Sep 2023info

Fiscal Q3 2023 ended 9/30/23. Reported on 10/31/23.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

2.37M14.37%

Operating expense

Represents the total incurred expenses through normal operations

20.64M2.73%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-16.74M3.19%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

-705.5615.35%

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

-0.16

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-17.67M-0.19%

Effective tax rate

The percent of their income that a corporation pays in taxes

Total assets

Total liabilities

(USD)Sep 2023info

Fiscal Q3 2023 ended 9/30/23. Reported on 10/31/23.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

149.14M-29.87%

Total assets

The total amount of assets owned by a company

189.78M-23.51%

Total liabilities

Sum of the combined debts a company owes

45.79M26.97%

Total equity

The value of subtracting the total liabilities from the total assets of a company

143.99M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

96.11M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

0.57

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-22.43%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-29.28%

Net change in cash

(USD)Sep 2023info

Fiscal Q3 2023 ended 9/30/23. Reported on 10/31/23.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-16.74M3.19%

Cash from operations

Net cash used or generated for core business activities

-19.57M2.37%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

-322.00K-311.84%

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

-837.00K-2.32%

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

-24.83M29.67%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-13.63M-3.97%

US listed security

Listed on NASDAQ

Previous close

The last closing price

$0.85

Year range

The range between the high and low prices over the past 52 weeks

$0.65 - $2.37

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

149.90M USD

Avg Volume

The average number of shares traded each day over the past 30 days

57.74K

About

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia

Founded

Mar 29, 2002

Employees

97

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexDow Jones Industrial Average38,661.050.00%
TSLATesla Inc$176.540.00%
AAPLApple Inc$169.120.00%
AMZNAmazon.com Inc$173.510.00%
BABAAlibaba Group Holding Ltd - ADR$73.710.00%
FFord Motor Co$12.380.00%
NXSTNexstar Media Group Inc$160.650.00%
BABoeing Co$201.000.00%
IndexNasdaq Composite16,031.540.58%
IndexVIX14.341.10%
MSFTMicrosoft Corp$402.090.00%
CCLCarnival Corp$16.010.00%
DISWalt Disney Co$110.060.00%
WMTWalmart Inc$60.570.00%
NFLXNetflix Inc$597.690.00%

People also search for

MCRBSeres Therapeutics Inc$1.010.00%
DNLIDenali Therapeutics Inc$20.520.34%
PRLDPrelude Therapeutics Inc$4.170.48%
CDTXCidara Therapeutics Inc$0.700.086%
BCYCBicycle Therapeutics PLC$24.640.081%
ROIVROIV$11.570.00%
IMVTImmunovant Inc$33.060.00%
VERUVeru Inc$0.640.00%
CTXRCitius Pharmaceuticals Inc$0.720.00%
IDYAIdeaya Biosciences Inc$46.360.00%
STOKStoke Therapeutics Inc$7.970.00%
IGMSIGM Biosciences Inc$12.221.08%
AKROAkero Therapeutics Inc$30.000.00%
ADAPAdaptimmune Therapeutics PLC - ADR$1.710.00%
RYTMRhythm Pharmaceuticals Inc$41.100.00%
CARACara Therapeutics Inc$0.990.00%
NKTRNektar Therapeutics$0.910.00%
ARGXargenx SE - ADR$390.660.00%

DBV Technologies SA - ADR (DBVT) Price & News - Google Finance (2)HelpSend feedbackPrivacyTermsDisclaimer

DBV Technologies SA - ADR (DBVT) Price & News - Google Finance (2024)

References

Top Articles
Latest Posts
Article information

Author: Kareem Mueller DO

Last Updated:

Views: 6127

Rating: 4.6 / 5 (66 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Kareem Mueller DO

Birthday: 1997-01-04

Address: Apt. 156 12935 Runolfsdottir Mission, Greenfort, MN 74384-6749

Phone: +16704982844747

Job: Corporate Administration Planner

Hobby: Mountain biking, Jewelry making, Stone skipping, Lacemaking, Knife making, Scrapbooking, Letterboxing

Introduction: My name is Kareem Mueller DO, I am a vivacious, super, thoughtful, excited, handsome, beautiful, combative person who loves writing and wants to share my knowledge and understanding with you.